IFN-γ modulates Ly-49 receptors on NK cells in IFN-γ-induced pregnancy failure

We have previously shown that interferon gamma (IFN-γ) induces aberrant CD49b + natural killer (NK) cell recruitment by regulating CX3CL1 and eventually provokes foetal loss. In this study, we show that IFN-γ also modulates Ly-49 receptors on NK cells during pregnancy failure. The percentages of Ly-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2015-12, Vol.5 (1), p.18159-18159, Article 18159
Hauptverfasser: Li, Zhong-Yin, Song, Zhi-Hui, Meng, Chao-Yang, Yang, Dan-Dan, Yang, Ying, Peng, Jing-Pian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We have previously shown that interferon gamma (IFN-γ) induces aberrant CD49b + natural killer (NK) cell recruitment by regulating CX3CL1 and eventually provokes foetal loss. In this study, we show that IFN-γ also modulates Ly-49 receptors on NK cells during pregnancy failure. The percentages of Ly-49A + and Ly-49G2 + NK cells in the uteri of the IFN-γ-treated group were significantly lower than those observed in the control group. Moreover, the median fluorescence intensity (MFI) values of Ly-49A and Ly-49G2 expression on NK cells in the uteri of the IFN-γ-treated group were significantly lower than those of the control group. Using isolated spleen leucocytes, we further found that IFN-γ significantly reduced the percentage of Ly-49A + NK cells in vitro . However, CX3CL1 was not involved in the modulation of Ly-49 receptors and the expression of CX3CR1 was not regulated by IFN-γ in spleen leucocytes. Collectively, our data indicate that IFN-γ can modulate Ly-49 receptors on NK cells and this process may play a role in IFN-γ-induced pregnancy failure. Thus, we provide a new line of evidence correlating the deleterious effects of IFN-γ with its role in regulating NK cell Ly-49 receptors during pregnancy failure.
ISSN:2045-2322
2045-2322
DOI:10.1038/srep18159